OCS vs Stroke Rehab

OCS-Plus provides health professionals with a brief cognitive assessment focussed on memory and executive attention. OCS-Plus was developed by the Translational Neuropsychology Research Group at the University of Oxford. The tool has been standardised, normed and validated (Demeyere et al 2021). The tool is currently undergoing further research for validity of use in specific clinical groups. The tool is not for self-assessment. Instead, a health professional assessor administers the screen to respondents to investigate domain-general cognitive impairments, with a specific focus on memory and executive attention. The tool contains multiple easy to administer tests and instructions are provided for each test. Normative data is provided for three age groups : under 60, between 60 and 70, and older than 70 and respondent performance is automatically compared to established normative cut offs. In order to activate the app for use, registration is required. There is no cost for the standard app version where data is not uploaded. Where data upload is required, an administration fee, as well as a collaboration agreement and datasharing agreement is required to be put in place.

Stroke Rehab is a comprehensive clinical reference tool for healthcare professionals involved in stroke rehabilitation. Built for neurologists, stroke physicians, physiotherapists, occupational therapists, speech and language therapists, and specialist nurses. Content is based on NICE NG236 (2023), the RCP National Clinical Guideline for Stroke (2023), ESO guidelines, and over 20 key randomised controlled trials including AVERT, EXCITE, LEAPS, FLAME, FOCUS, and the Cochrane ESD meta-analysis. 8 CLINICAL DOMAINS 1. Organisation and Early Assessment MDT goal-setting within 72 hours, SMART goals, intensity targets, NIHSS, MoCA, Barthel Index, swallow screening, and continence assessment. 2. Motor Recovery and Physiotherapy Constraint-induced movement therapy (CIMT), robot-assisted therapy, mirror therapy, mental practice, the 3-hour daily therapy target from RCP 2023, and the AVERT trial findings on early mobilisation. 3. Walking and Balance Rehabilitation LEAPS trial evidence, treadmill and overground training, functional electrical stimulation (FES) for foot drop, ankle-foot orthosis, aerobic exercise, falls prevention, and functional walking speed targets. 4. Communication and Aphasia Aphasia classification table, SALT intensity targets (45 min/day), constraint-induced aphasia therapy, augmentative and alternative communication (AAC), dysarthria management, and dysphagia assessment including IDDSI texture levels and PEG timing. 5. Cognition, Mood and Fatigue Post-stroke cognitive impairment screening (MoCA), cognitive rehabilitation strategies, post-stroke depression (PHQ-9, HADS), emotionalism, anxiety, and a dedicated fatigue management section reflecting the new NICE NG236 2023 guidance. 6. ADL, Spasticity and Shoulder Pain Occupational therapy and personal and instrumental ADL rehabilitation, stepped spasticity management (physiotherapy, oral agents, botulinum toxin per NICE TA491), intrathecal baclofen, and hemiplegic shoulder pain including NMES and FES recommendations. 7. Community Discharge and Early Supported Discharge (ESD) ESD eligibility criteria based on the Cochrane ESD meta-analysis (2017), pre-discharge checklist, driving and DVLA guidance, return to work (new NICE NG236 2023 section), telerehabilitation, annual review, and carer support. 8. Assessment Scales and Outcome Measures Complete reference for modified Rankin Scale (mRS 0-6), Barthel Index with dependency thresholds, Fugl-Meyer Assessment with MCID values, NIHSS severity banding, MoCA, FIM, Rivermead Motor Assessment, and SSNAP. REFERENCES All 21 references are fully cited with clickable links opening directly to PubMed or official guideline sources, including NICE NG236, RCP 2023, AVERT (Lancet 2015), EXCITE (JAMA 2006), LEAPS (NEJM 2011), FLAME (Lancet Neurol 2011), FOCUS (Lancet 2019), Brady Cochrane aphasia review (2022), FOOD trial, NICE TA491, Cochrane stroke unit review, ESD Cochrane review, and the original mRS and Fugl-Meyer validation papers. FEATURES - Adjustable font size (A- / A+) for bedside use - Fully offline after first load, no internet required for content - Dark theme optimised for low-light clinical environments - Interactive checklists for MDT assessment and pre-discharge planning - Persistent bottom navigation across all 8 domains For qualified healthcare professionals only. Not a substitute for clinical judgement or specialist review. Not a regulated medical device.